Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY ™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Health | Sickle Cell Anemia